Leidos Biomedical Research Inc — Federal Contractor Profile
Leidos Biomedical Research: A Giant in Government Health and Scientific Research Contracts
Contractor Overview
Total Contract Value: $587,877,540,669 ($587.9B)
Total Awards: 346
Company Profile
LEIDOS BIOMEDICAL RESEARCH INC is a significant player in the federal contracting landscape, primarily focused on scientific research and development, particularly within the health and biomedical sectors. Their core capabilities revolve around managing and executing complex research programs, often involving large-scale data analysis, laboratory operations, and the development of advanced technologies for health and national security. The company's relationship with government agencies is deeply rooted in supporting critical scientific missions. Their substantial contract value, exceeding $59 billion across 27 contracts, indicates a strong and consistent demand for their specialized services. The average contract size of over $2.2 billion suggests they are involved in very large, long-term, and complex projects. While specific contract details regarding competitive versus sole-source awards are not provided in the summary data, the sheer volume and value of their contracts imply a history of winning significant, often sole-source or limited-competition, awards due to their unique expertise and established infrastructure. LEIDOS BIOMEDICAL RESEARCH INC has a track record of managing large government research initiatives, though specific notable projects are not detailed here. Their business strategy appears to be centered on securing and executing large, mission-critical research and development contracts, leveraging deep scientific expertise and operational capacity to serve government needs in specialized areas.
Specializations
- Biomedical Research and Development
- Health Data Analysis
- Laboratory Operations Management
- Scientific Program Management
- Advanced Technology Development for Health
- National Security Research Support
- Clinical Trial Management
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: Unknown
Agency Concentration: Unknown
Growth Trajectory: Unknown
Competitive Position
LEIDOS BIOMEDICAL RESEARCH INC appears to be a dominant player in its specialized niche of government-funded biomedical research and development. Their substantial contract portfolio suggests they possess unique capabilities and infrastructure that are highly sought after by federal agencies. This positions them as a go-to contractor for large-scale, complex scientific endeavors, likely facing limited direct competition for many of their core services.
Value to Taxpayers
Given the immense value of contracts awarded to LEIDOS BIOMEDICAL RESEARCH INC, assessing value to taxpayers requires a deeper dive into project outcomes and cost-effectiveness. The large average contract size suggests significant investments in critical research areas. However, without data on competitive bidding, cost overruns, or successful project delivery metrics, it is difficult to definitively state whether these contracts represent optimal value. Their specialization in complex scientific research implies that specialized expertise is necessary, which may justify higher costs, but transparency on performance is key.
Agency Relationships
While top agency clients are not specified, LEIDOS BIOMEDICAL RESEARCH INC's focus on biomedical research strongly suggests significant reliance from agencies like the National Institutes of Health (NIH), Department of Defense (DoD) health programs, and potentially agencies involved in public health and national security. These agencies likely depend on Leidos for their specialized scientific expertise, infrastructure, and ability to manage large, long-term research initiatives.
Red Flags
- Lack of recent contract data: The absence of recent contracts could indicate a slowdown or a shift in their contracting patterns, which warrants further investigation.
- Unknown competitive win rate: Without knowing how many contracts were won competitively versus sole-source, it's difficult to assess market competition and potential for cost savings through bidding.
Green Flags
- Massive contract value: The $59.91 billion in contracts indicates a high level of trust and sustained demand from the government for their services.
- Large number of contracts for its value: 27 contracts totaling $59.91 billion suggests a consistent pipeline of significant work, rather than a few outlier mega-deals.
Key Contracts
LEIDOS BIOMEDICAL RESEARCH INC's government contracting profile is dominated by its substantial total contract value of $59.91 billion across 27 contracts, with an average size exceeding $2.2 billion. This indicates a deep and ongoing engagement with federal agencies requiring extensive scientific research and development capabilities. While specific contract titles and descriptions are not provided in the summary data, the sheer scale of their awards points towards involvement in major, long-term government initiatives. These likely include managing large-scale research programs, operating significant laboratory facilities, and providing advanced analytical services for health and potentially national security-related projects. The high average contract value suggests that LEIDOS BIOMEDICAL RESEARCH INC is entrusted with complex, mission-critical tasks that demand specialized scientific expertise, robust project management, and substantial operational infrastructure. Such contracts often involve areas like infectious disease research, cancer research, development of medical countermeasures, or advanced data analytics for public health surveillance. The company's ability to secure and manage contracts of this magnitude underscores its critical role in supporting the scientific and research objectives of various government bodies, positioning it as a key partner in advancing scientific knowledge and addressing national health challenges.
Frequently Asked Questions
What does LEIDOS BIOMEDICAL RESEARCH INC do for the government?
LEIDOS BIOMEDICAL RESEARCH INC specializes in providing scientific research and development services to the U.S. government. Their core capabilities include managing complex research programs, operating laboratories, analyzing health data, and developing advanced technologies, particularly in the biomedical and health sectors. They support critical government missions related to public health, disease research, and national security by leveraging their deep scientific expertise and operational capacity to execute large-scale, long-term research initiatives.
How much taxpayer money does LEIDOS BIOMEDICAL RESEARCH INC receive?
LEIDOS BIOMEDICAL RESEARCH INC has received a total of $59.91 billion in government contracts across 27 awards. This substantial amount reflects their significant role in government spending. The average contract size is approximately $2.22 billion, indicating that they are involved in very large and complex projects. This figure represents the total value of awarded contracts, not necessarily the amount spent to date.
Is LEIDOS BIOMEDICAL RESEARCH INC good value for taxpayer money?
Assessing the value LEIDOS BIOMEDICAL RESEARCH INC provides to taxpayers is challenging without more detailed performance data. The company's extensive contract portfolio and large average contract sizes suggest they are delivering critical scientific research and development services that the government deems essential. However, the lack of information on competitive win rates and specific project outcomes makes it difficult to determine if these contracts represent the most cost-effective solutions. Further analysis of project success metrics and cost efficiency would be needed for a definitive assessment.
How does LEIDOS BIOMEDICAL RESEARCH INC win its contracts?
The provided data does not specify the patterns of how LEIDOS BIOMEDICAL RESEARCH INC wins its contracts (e.g., competitive bidding vs. sole-source awards). However, the extremely large average contract size of over $2.2 billion suggests that many of their awards may be for complex, specialized research and development projects where competition might be limited due to unique expertise or existing infrastructure. A deeper analysis of individual contract awards would be necessary to understand their win strategy.
What agencies use LEIDOS BIOMEDICAL RESEARCH INC most?
The summary data does not explicitly list the top agency clients for LEIDOS BIOMEDICAL RESEARCH INC. However, given their specialization in biomedical research, it is highly probable that agencies such as the National Institutes of Health (NIH), the Department of Defense (DoD) for health-related research, and potentially agencies focused on public health and national security are their primary clients. These agencies would rely on Leidos for their scientific expertise and capacity to manage large research programs.